AVITA Medical
RCEL
#7570
Rank
A$0.72 B
Marketcap
A$23.07
Share price
-3.52%
Change (1 day)
302.79%
Change (1 year)
Categories

P/E ratio for AVITA Medical (RCEL)

P/E ratio as of November 2026 (TTM): -10.9

According to AVITA Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -10.934. At the end of 2022 the company had a P/E ratio of -6.17.

P/E ratio history for AVITA Medical from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-6.17-46.97%
2021-11.628.96%
2020-9.02

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Organovo
ONVO
-0.1771-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-2.69-75.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-5.72-47.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-10.9 0.09% Jersey

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.